MiR-202-3p functions as a tumor suppressor and reduces cell migration and invasion in papillary thyroid carcinoma
J. Chen, J. Yin, J. Liu, R.-X. Zhu, Y. Zheng, X.-L. Wang Department of General surgery, Affiliated Haian Hospital of Nantong University, Haian County of Nantong City, China. ktg917986719833@163.com
OBJECTIVE: MicroRNAs (miRNAs) are recently identified as key regulators of tumor development and progression. MiR-202-3p functions as tumor suppressor in some cancer types. The aim of the study is to determine its expression pattern and explore the functions underlying the mechanism of miR-202-3p in papillary thyroid carcinoma (PTC).
PATIENTS AND METHODS: By using quantitative RT-PCR (QRT-PCR) analyses, we detected miR-202-3p expression in PTC tissues and cell lines. Transwell migration and invasion assays were performed to measure the migration and invasion ability of tumor cells transfected with miR-202-3p mimic. Western blot analysis was used to detect the protein expression.
RESULTS: Our results showed that miR-202-3p expression was frequently downregulated in 96 cases PTC tissues compared to adjacent normal tissues. Lower expression of miR-202-3p associated with lymph node metastasis of patients with PTC. Overexpression of miR-202-3p inhibited cell migration and invasion in TPC-1 and BCPAP cells. Furthermore, enforced expression of miR-202-3p inhibited WNT signaling by downregulating β-catenin expression in TPC-1 and BCPAP cells.
CONCLUSIONS: Our findings indicated that miR-202-3p may represent a novel therapeutic target of in PTC.
Free PDF DownloadThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
To cite this article
J. Chen, J. Yin, J. Liu, R.-X. Zhu, Y. Zheng, X.-L. Wang
MiR-202-3p functions as a tumor suppressor and reduces cell migration and invasion in papillary thyroid carcinoma
Eur Rev Med Pharmacol Sci
Year: 2019
Vol. 23 - N. 3
Pages: 1145-1150
DOI: 10.26355/eurrev_201902_17005